The Hair System Daily — 2026-08-07

[Sam] It completely changes the economic equation for barbers. You don't need to be a custom base artisan to offer hair systems anymore. But the report notes that fulfillment lead times and direct-to-consumer channels are creating a divide: salons that stock versatile pre-cuts and master quick bonding services are capturing the market much faster than those relying on traditional custom ordering cycles. [Alex] That integration of care is happening on the clinical side, too. Over in the UK, the Imperial College Healthcare NHS Trust published their holistic alopecia model, combining medical dermatology, dedicated psychological counseling, and on-site wig prescription services. [Sam] It's a powerful validation of what system specialists have known for years: hair replacement isn't cosmetic vanity; it's identity preservation. And we saw a deeply personal account of this recently in Cure Today, detailing a patient's journey navigating chemotherapy-induced hair loss. [Alex] The patient highlighted how critical early, pre-treatment wig consultations were—matching hair direction, density, and style *before* shedding started. For practitioners, it underscores why medical hair loss consultations require a totally different timeline and empathetic touch than routine cosmetic updates. [Sam] Now, let's turn to science, because two non-surgical therapeutic studies just dropped that every consultant should have on their radar when advising clients in the early stages of thinning. [Alex] First, the 12-month Phase 3 trial data for clascoterone 5% topical solution—a topical anti-androgen tested across nearly 1,500 male participants in the US and Europe. It targeted androgen receptors directly in the scalp, showing sustained density improvements without systemic hormonal side effects. [Sam] That local action is the holy grail for clients who refuse oral finasteride due to side effect risks. And published alongside that in the Journal of Cosmetic Dermatology, a pilot study evaluated a wearable electrotrichogenic device—low-level electrical stimulation worn 30 minutes daily. [Alex] The numbers were surprising for a physical intervention: a 19.3% increase in total scalp hair density and an 8.8% increase in shaft thickness over six months, with zero adverse events. [Sam] So what does this mean for a modern hair system studio? It means your prospective client base is becoming more educated on non-invasive therapies. Understanding where topical blockers or physical stimulation fit into a client's journey helps you guide them transitionally—whether that's preserving native hair or preparing them for a partial system down the line. [Alex] It's all about providing a continuum of care. That's all for today's briefing. Thanks for joining us on The Hair System Daily. [Sam] We'll see you tomorrow.